Anti-tumor immunity

Edit Answers
12345678910111213141516
Across
  1. 3. Professional antigen-presenting cells.
  2. 4. Chronic functional state of T lymphocytes caused by persistent antigen exposure in the tumor microenvironment.
  3. 5. Formation of new blood vessels in tumors.
  4. 9. Molecule expressed by tumors that suppresses T-cell activity.
  5. 11. Tumor microenvironment condition caused by low oxygen concentration
  6. 12. therapeutic strategy that blocks PD-1 or CTLA-4 signaling pathways
  7. 14. Spread of tumor cells to distant organs
  8. 15. Cytotoxic proteins released by NK and CD8+ T cells to destroy tumor cells.
Down
  1. 1. Highly immunogenic mutation-derived tumor antigens
  2. 2. Process by which tumor cells reduce antigen presentation to avoid recognition by CD8+ T lymphocytes.
  3. 6. Immune cells that can kill tumor cells without antigen-specific activation.
  4. 7. Process by which activated T cells migrate into tumor tissue
  5. 8. Main function of CD8+ T cells.
  6. 10. Site where naïve T cells are activated.
  7. 13. Immunologically active tumors rich in T-cell infiltration are called ____ tumors
  8. 16. Macrophage subtype associated with tumor promotion.